Dr Hu is an Assistant Professor of Medicine in the Division of Medical Oncology at the University of Kansas Medical Center and a member of the KU Cancer Center. He received his MD degree from the Columbia University College of Physicians and Surgeons in New York and completed his clinical training in Internal Medicine and Hematology/Medical Oncology at the Yale University/Yale New Haven Hospital. He also earned a PhD degree in Genetics from Case Western Reserve University in Cleveland Ohio, followed by a postdoctoral research fellowship at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts. 

At KUMC, he is specialized in breast cancer medical oncology and partners with providers from multidisciplinary teams to provide care to all patients who are diagnosed with breast cancer. His clinical interests include triple negative breast cancer, HER2 positive breast cancer, early onset breast cancer, and breast cancer associated with genetic cancer predisposition syndromes.

Dr Hu has a long-standing research interest in basic and translational breast cancer research, and his focused areas of research include DNA damage and genome stability control, cancer predisposition syndromes associated with defective DNA repair, and the crosstalk between DNA damage, chromosomal instability, and tumor immune responses. His overarching research goal is to develop novel biomarkers and identify new therapeutic targets to promote personalized breast cancer treatment.